Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Hilton Grand Vacations
HGV
$4.14B
| $17.1M | ﹤0.01% |
381,188
+19,478
| +5% | +$827K |
|
3077
Seaboard Corp
SEB
$4.36B
| $17M | ﹤0.01% |
3,827
+1,092
| +40% | +$4.32M |
|
|
GTY
3078
Getty Realty Corp
GTY
$2.12B
| $17M | ﹤0.01% |
620,412
-3,111
| -0.5% | -$86K |
|
3079
Nuveen Real Asset Income & Growth Fund
JRI
$354M
| $17M | ﹤0.01% |
1,246,761
-87,569
| -7% | -$1.2M |
|
|
SEZL
3080
Sezzle
SEZL
$5.28B
| $17M | ﹤0.01% |
267,067
+39,572
| +17% | +$2.7M |
|
|
FTMA
3081
Franklin Massachusetts Municipal Income ETF
FTMA
$287M
| $16.9M | ﹤0.01% |
+1,877,377
| New | +$16.9M |
|
3082
Columbia Diversified Fixed Income Allocation ETF
DIAL
$388M
| $16.9M | ﹤0.01% |
921,138
+22,700
| +3% | +$418K |
|
3083
Capricor Therapeutics
CAPR
$380M
| $16.9M | ﹤0.01% |
585,840
+34,146
| +6% | +$446K |
|
|
HFRO
3084
Highland Opportunities and Income Fund
HFRO
$406M
| $16.9M | ﹤0.01% |
2,822,936
-364,695
| -11% | -$2.28M |
|
3085
Lindsay Corp
LNN
$1.17B
| $16.9M | ﹤0.01% |
143,207
+19,014
| +15% | +$2.29M |
|
3086
Franklin FTSE Germany ETF
FLGR
$37.6M
| $16.9M | ﹤0.01% |
503,182
+272,191
| +118% | +$8.91M |
|
3087
Limbach Holdings
LMB
$864M
| $16.9M | ﹤0.01% |
216,518
+18,673
| +9% | +$1.54M |
|
|
DMC
3088
Del Monte Corp
DMC
$1.37B
| $16.9M | ﹤0.01% |
472,936
+27,572
| +6% | +$984K |
|
3089
Phibro Animal Health
PAHC
$1.48B
| $16.7M | ﹤0.01% |
447,312
+11,270
| +3% | +$458K |
|
|
DEA
3090
Easterly Government Properties
DEA
$1.17B
| $16.7M | ﹤0.01% |
788,421
+138,473
| +21% | +$3.01M |
|
3091
GigaCloud Technology
GCT
$1.5B
| $16.7M | ﹤0.01% |
425,045
+92,934
| +28% | +$3.07M |
|
|
EDD
3092
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$378M
| $16.7M | ﹤0.01% |
3,068,940
+179,607
| +6% | +$973K |
|
3093
Olema Pharmaceuticals
OLMA
$1.01B
| $16.6M | ﹤0.01% |
665,803
-890,084
| -57% | -$15.8M |
|
|
EOI
3094
Eaton Vance Enhanced Equity Income Fund
EOI
$804M
| $16.6M | ﹤0.01% |
809,564
-10,364
| -1% | -$210K |
|
3095
Geron
GERN
$930M
| $16.6M | ﹤0.01% |
12,603,418
+1,905,062
| +18% | +$2.39M |
|
3096
ARK Blockchain & Fintech Innovation ETF
ARKF
$744M
| $16.6M | ﹤0.01% |
348,670
-53,909
| -13% | -$2.81M |
|
3097
Northwest Bancshares
NWBI
$2.33B
| $16.6M | ﹤0.01% |
1,382,107
-11,157
| -0.8% | -$136K |
|
|
LAC
3098
Lithium Americas
LAC
$972M
| $16.6M | ﹤0.01% |
3,799,231
+2,492,321
| +191% | +$14.4M |
|
3099
PLDT
PHI
$4.32B
| $16.5M | ﹤0.01% |
759,639
+87,066
| +13% | +$1.79M |
|
3100
S&T Bancorp
STBA
$1.92B
| $16.5M | ﹤0.01% |
418,692
+4,220
| +1% | +$163K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.